Latest News

Welcome to the new Parkview Lab Website

Welcome to the new Parkview Health Laboratory website!

On July 1, 2025, Parkview Health laboratories will discontinue in-house testing of LAB2467-Urine Eosinophils (EOSO) on recommendation of the Laboratory Stewardship Committee and the American Society for Clinical Pathology (ASCP).

Learn More

Coagulation Reference Range Change 5/13/2025

Changes effective 5/13/2025 after 10am:

Prothrombin time: 9.5-12.0 seconds (currently 10.2-12.0 seconds)
INR 0.9-1.1 (no change)
aPTT: 23.5-33.0 seconds (currently: 24.2-33.0 seconds)

The unfractionated heparin therapeutic range remains unchanged.

Questions: Contact Dr. Grace Xie at 266-1640 or Leslie Chaparro at 266-6085.

Fentanyl added to Parkview's Urine Drug Screen

Effective April 29, the components of the Urine Drug Screen (EPIC TC LAB2673) will be updated to better reflect those substances being used and/or abused in our communities.

Learn More

Parkview Health Laboratories Tests

Parkview Health Laboratories offers a wide variety of comprehensive diagnostic tests. Search by test name, included tests, and relevant test codes. Not sure about the name? Feel free to search by first letter.

Search For a Test

Reasons to be a PHL Client

Parkview Health Laboratories' (PHL) primary focus is on quality; quality in testing, quality in data handling and reporting. We make every effort to ensure consistent quality throughout PHL.

MLS Program

The Parkview Medical Laboratory Science Program provides an up-to-date curriculum designed to prepare graduates with the skills and knowledge demanded of a medical laboratory scientist.

Direct Access Testing

Parkview Health Laboratories offers Direct Access Testing (DAT) for select lab tests. For these tests, DAT eliminates the need for a physician's order. This convenient service provides an out-of-pocket option for those without health insurance, or who don't want to file a claim through their health insurance.